Publications by authors named "David D Stenehjem"

Claim this Profile
P
Pharmacogenomics case-based education: Establishment of an Extension for Community Health Outcomes (ECHO) education model for healthcare professionals.
Pamala A Jacobson, Alyssa N K Johnson, Jeffrey R Bishop, Jordan Baye, Natasha J Petry, David D Stenehjem

Am J Health Syst Pharm· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to measuring frailty.
Meena N Murugappan, Bellinda L King-Kallimanis, Vishal Bhatnagar, Bindu Kanapuru, Joel F Farley, David D Stenehjem

J Geriatr Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma.
Meena N Murugappan, Bellinda L King-Kallimanis, Vishal Bhatnagar, Bindu Kanapuru, Joel F Farley, David D Stenehjem

Qual Life Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High rifaximin out-of-pocket costs are associated with decreased treatment retention among patients with hepatic encephalopathy.
Elizabeth S Aby, Tsung-Hua Shen, Meena N Murugappan, David D Stenehjem, Thomas M Leventhal

Hepatol Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer incidence in immunocompromised patients: a single-center cohort study.
Sabrina Ilham, Connor Willis, Kibum Kim, Karen C Chung, Brenda M Wood, David D Stenehjem

BMC Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of metformin on tyrosine kinase inhibitor response in chronic myeloid leukemia.
Rebecca Pokorny, David D Stenehjem, Jeffrey A Gilreath

J Oncol Pharm Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?
Eman Biltaji, Brandon Walker, Trang H Au, Zachary Rivers, Jennifer Ose, David D Stenehjem

Cancer Epidemiol Biomarkers Prev· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA testing and outcomes in women with breast cancer.
David D Stenehjem, Claire Telford, Sudhir K Unni, Hillevi Bauer, Amy Sainski

Breast Cancer Res Treat· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating pharmacogenetic testing via medication therapy management in an outpatient family medicine clinic.
Jacob T Brown, Danielle MacDonald, Ann Yapel, Tiana Luczak, Anna Hanson, David D Stenehjem

Pharmacogenomics· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness of Nivolumab Monotherapy After Prior Systemic Therapy in Advanced Non-Small-Cell Lung Cancer in the United States.
David D Stenehjem, Solomon J Lubinga, Komal Gupte-Singh, Ying Zhang, Trong Kim Le

Clin Lung Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist's attitudes and knowledge of pharmacogenomics and the factors that may predict future engagement.
Megan E Hundertmark, Stephen C Waring, David D Stenehjem, Dannielle A Macdonald, David J Sperl

Pharm Pract (Granada)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and safety of interventions for preventing chemotherapy-induced oral mucositis in adult cancer patients: a systematic review and network meta-analysis.
Preyanate Wilairat, Kirati Kengkla, Thanatchai Kaewpanan, Jirapat Kaewthong, Sorave Ruankon, David D Stenehjem

Eur J Hosp Pharm· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center.
David D Stenehjem, Trang H Au, Surachat Ngorsuraches, Junjie Ma, Hillevi Bauer

Melanoma Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor mutational burden in lung cancer: a systematic literature review.
Connor Willis, Michelle Fiander, Dao Tran, Beata Korytowsky, John-Michael Thomas, David D Stenehjem

Oncotarget· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma.
David D Stenehjem, Andrew W Hahn, David M Gill, Daniel Albertson, Banumathy Gowrishankar

PLoS One· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to Oral Medications During Maintenance Therapy Among Children and Adolescents With Acute Lymphoblastic Leukemia: A Medication Refill Analysis.
Yelena P Wu, David D Stenehjem, Lauri A Linder, Bin Yu, Bridget Grahmann Parsons

J Pediatr Oncol Nurs· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer.
G Weldon Gilcrease, David D Stenehjem, Mark L Wade, John Weis, Kimberly McGregor

Invest New Drugs· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time from definitive therapy to onset of metastatic disease predicts outcomes in men with metastatic hormone sensitive prostate cancer.
Andrew W Hahn, David D Stenehjem, Anitha B Alex, David M Gill, Heather H Cheng

Urol Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports.
Jeffrey A Gilreath, Mei Wei, Shilpa Paul, Charles J Parker, David D Stenehjem

J Oncol Pharm Pract· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Bacteroides in Stool Microbiome and Response to Treatment With First-Line VEGF Tyrosine Kinase Inhibitors in Metastatic Renal-Cell Carcinoma.
Andrew W Hahn, Camryn Froerer, Sidney VanAlstine, Nityam Rathi, Erin B Bailey, David D Stenehjem

Clin Genitourin Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer.
David D Stenehjem, Dao Tran, Michael A Nkrumah, Shilpa Gupta

Onco Targets Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and survival of patients with metastatic basal cell carcinoma in the Department of Veterans Affairs: a retrospective electronic health record review.
Vanessa W Stevens, David D Stenehjem, Olga V Patterson, Aaron W C Kamauu, Yeun Mi Yim

Arch Dermatol Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitors.
Erin B Bailey, Joseph Merriman, Benjamin Maughan, Austin Poole, Srinivas K Tantravahi, David D Stenehjem

J Oncol Pharm Pract· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Care Clinicians Attitudes and Knowledge of Pharmacogenetics in a Large, Multi-state, Healthcare System.
Megan Olander, Stephen Waring, David D Stenehjem, Allise Taran, Paul Ranelli

Innov Pharm· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a genetic counseling requirement prior to genetic testing.
David D Stenehjem, Trang Au, Amy M Sainski, Hillevi Bauer, Krystal Brown

BMC Health Serv Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis